A phase II, randomized, safety and immunogenicity study of a re-derived, live-attenuated dengue virus vaccine in healthy adults (Q36523070)

14 August 2017

A phase II, randomized, safety and immunogenicity study of a re-derived, live-attenuated dengue virus vaccine in healthy adults (English)

1 reference

14 August 2017

0 references

1 reference

Jean-Francois Toussaint

object named as

Jean-Francois Toussaint

8

0 references

Bruce L. Innis

object named as

Bruce L Innis

12

0 references

Rafael A De La Barrera

4

object named as

Rafael De La Barrera

1 reference

14 August 2017

2

Kenneth H Eckels

1 reference

14 August 2017

Stephen J Thomas

1

1 reference

14 August 2017

Isabelle Carletti

3

1 reference

14 August 2017

Francis Dessy

5

1 reference

14 August 2017

Stefan Fernandez

6

1 reference

14 August 2017

Robert Putnak

7

1 reference

14 August 2017

Wellington Sun

9

1 reference

14 August 2017

Kristen Bauer

10

1 reference

14 August 2017

Robert V Gibbons

11

1 reference

14 August 2017

language of work or name

English

0 references

publication date

3 December 2012

1 reference

American Journal of Tropical Medicine and Hygiene

14 August 2017

16

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

14 August 2017

88

1 reference

14 August 2017

1

1 reference

14 August 2017

73-88

1 reference

Safety and immunogenicity of a tetravalent live-attenuated dengue vaccine in flavivirus-naive infants

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541749

Interference and facilitation between dengue serotypes in a tetravalent live dengue virus vaccine candidate

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541749

Acute myocarditis in dengue hemorrhagic fever: a case report and review of cardiac complications in dengue-affected patients

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541749

A novel tetravalent dengue vaccine is well tolerated and immunogenic against all 4 serotypes in flavivirus-naive adults

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541749

Dengue Plaque Reduction Neutralization Test (PRNT) in Primary and Secondary Dengue Virus Infections: How Alterations in Assay Conditions Impact Performance

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541749

Phase 2 clinical trial of three formulations of tetravalent live-attenuated dengue vaccine in flavivirus-naïve adults

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541749

A new quantitative RT-PCR method for sensitive detection of dengue virus in serum samples

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541749

Safety and immunogenicity of a tetravalent live-attenuated dengue vaccine in flavivirus naive children.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541749

Of cascades and perfect storms: the immunopathogenesis of dengue haemorrhagic fever-dengue shock syndrome (DHF/DSS).

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541749

Race: a risk factor for dengue hemorrhagic fever

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541749

Cost-effectiveness of a pediatric dengue vaccine

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541749

Progress in development of a live-attenuated, tetravalent dengue virus vaccine by the United States Army Medical Research and Materiel Command.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541749

Phase I trial of 16 formulations of a tetravalent live-attenuated dengue vaccine

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541749

Modification of dengue virus strains by passage in primary dog kidney cells: preparation of candidate vaccines and immunization of monkeys.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541749

Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3'-untranslated region.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541749

Human skin Langerhans cells are targets of dengue virus infection

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541749

Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541749

Quantitative relationship between oral temperature and severity of illness following inoculation with candidate attenuated dengue virus vaccines

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541749

The necessity and quandaries of dengue vaccine development

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541749

Dengue Vaccine: The Current Status

28 June 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23208878

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.4269/AJTMH.2012.12-0361

1 reference

14 August 2017

1 reference

14 August 2017

1 reference